HLF — Herbalife Nutrition Ltd.

Summary of Herbalife Nutrition Ltd. Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Net Sales: $1.3 billion, up 7.8% year-over-year and 5.4% on a constant currency basis, exceeding guidance (3%-7%).
• Adjusted EBITDA: $176 million, above guidance of $155 million to $175 million, with a margin of 13.3%.
• Net Income: $62 million; adjusted net income of $69 million; adjusted diluted EPS of $0.64.
• Cash from Operations: $114 million, a significant improvement from neutral cash flow in Q1 2025.
• Total Leverage Ratio: 2.7x; net leverage ratio introduced at 2.1x.
• Capital Expenditures: $11 million, at the low end of the $10 million to $20 million guidance range.

2. Strategic Updates and Business Highlights

• Debt Refinancing: Successfully refinanced $1.45 billion in senior secured debt, expected to save approximately $45 million in annual cash interest.
• Acquisitions: Completed the acquisition of Vionic's personalized nutrition business, enhancing product offerings and market reach.
• Personalization Strategy: Focus on evolving personalized nutrition through acquisitions (Vionic, Link Biosciences, Prüvit) and the Protocol platform, which aims to enhance distributor-customer engagement.
• Market Performance: Record quarterly net sales in India ($275 million, up 32% year-over-year) and strong growth in Asia Pacific and Latin America, offsetting declines in North America and EMEA.

3. Forward Guidance and Outlook

• Q2 2026 Guidance: Net sales expected to increase 1.5% to 5.5% year-over-year; adjusted EBITDA forecasted between $150 million and $170 million.
• Full-Year 2026 Guidance: Reported net sales growth projected at 1.5% to 5.5%; adjusted EBITDA expected in the range of $675 million to $705 million.
• India Market: Anticipated continued momentum despite the annualization of GST impacts; however, growth rates may moderate.

4. Bad News, Challenges, or Points of Concern

• Regional Weakness: Declines in North America (-3% year-over-year) and EMEA (1% growth but -6% in constant currency) due to various factors, including severe weather and a decline in distributor activity.
• China Market: Continued struggles with a 12% decline in net sales; currently represents only 4% of total sales with no immediate recovery expected.
• Input Cost Inflation: Gross profit margin decreased to 77.9%, impacted by input cost inflation and unfavorable sales mix.
• Tax Rate Increase: Adjusted effective tax rate rose to 27.3%, affecting EPS.

5. Notable Q&A Insights

• Protocol Platform: Still in beta testing; feedback is being incorporated to improve distributor engagement and customer interactions.
• India Pricing Strategy: The success of the GST reduction in India may lead to similar pricing strategies in other markets, with ongoing tests based on distributor feedback.
• Oil Prices Impact: Higher oil costs are currently being absorbed without passing on to consumers; potential indirect effects on consumer behavior noted.
• Personalization Strategy: The company is focused on tiering product offerings to cater to different demographics and price points, leveraging acquisitions to enhance personalization capabilities.
• Distributor Engagement: Efforts to improve distributor training and engagement are yielding positive results, with new distributor growth up 13% on a two-year stack basis since the launch of the Herbalife Premier League.

Overall, Herbalife Nutrition Ltd. reported a strong start to 2026, with significant growth in net sales and adjusted EBITDA, driven by strategic initiatives and acquisitions. However, challenges in certain regions and ongoing market dynamics present risks that the company is actively addressing.